MedTrace Logo

Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women

NCT07429734 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-24

No results posted yet for this study

Summary

The goal of the study is to compare the efficacy, safety and tolerability of solifenacin plus gabapentin versus solifenacin monotherapy for the treatment of women who are suffering from non-neurogenic ОАВ.

The main questions it aims to answer are:

Does combination of Solifenacin and Gabapentin affect the total score and sub-scores of OABSS in females with non-neurogenic ОАВ ? What medical problems do participants have when taking combination of Solifenacin and gabapentin ?

Conditions

Interventions

DRUG

solifenacin combined with gabapentin

using solifenacin combined with gabapentin for treatment of non-neurogenic overactive bladder in women

DRUG

solifenacin monotherapy

solifenacin monotherapy for treatment of non-neurogenic overactive bladder in women

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Urology and Nephrology center - Mansoura University · Urology and Nephrology center - Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2026-10-31
Completion
2027-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07429734 on ClinicalTrials.gov